Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Arcutis Biotherapeutics, Inc. (ARQT)

19.11   0.48 (2.58%) 10-01 11:43
Open: 18.59 Pre. Close: 18.63
High: 19.57 Low: 18.59
Volume: 1,025,692 Market Cap: 1,150(M)
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.59 - 19.67 19.67 - 19.74
Low: 18.38 - 18.47 18.47 - 18.55
Close: 18.95 - 19.1 19.1 - 19.23

Technical analysis

as of: 2022-09-30 4:26:15 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 27.36     One year: 32
Support: Support1: 17.01    Support2: 14.15
Resistance: Resistance1: 23.43    Resistance2: 27.39
Pivot: 18.93
Moving Average: MA(5): 18.64     MA(20): 19.66
MA(100): 22     MA(250): 19.94
MACD: MACD(12,26): -1.3     Signal(9): -1.4
Stochastic oscillator: %K(14,3): 36.7     %D(3): 30.7
RSI: RSI(14): 42.2
52-week: High: 27.39  Low: 13.59
Average Vol(K): 3-Month: 684 (K)  10-Days: 647 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ARQT ] has closed below upper band by 45.3%. Bollinger Bands are 31.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 27 Sep 2022
Arcutis Biotherapeutics (ARQT) Stock: Why It Increased Over 4.5% Today - Pulse 2.0

Tue, 20 Sep 2022
Arcutis Biotherapeutics Inc. (ARQT) Announces Publication of Roflumilast Cream 0.3% Results from DERMIS-1 and -2 Phase 3 Trials in Plaque Psoriasis -

Tue, 20 Sep 2022
Health Care Sector Update for 09/20/2022: ARQT,VIRI,RCOR,RCKT,VRAX - Nasdaq

Sun, 18 Sep 2022
Arcutis Biotherapeutics: A Name To Accumulate (NASDAQ:ARQT) - Seeking Alpha

Wed, 14 Sep 2022
ARQT Crosses Below Key Moving Average Level - Nasdaq

Mon, 12 Sep 2022
Arcutis: Roflumilast May Be A Pipeline In A Molecule (NASDAQ:ARQT) - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 60 (M)
Shares Float 42 (M)
% Held by Insiders 3.2 (%)
% Held by Institutions 80.5 (%)
Shares Short 5,120 (K)
Shares Short P.Month 4,580 (K)

Stock Financials

EPS -4.68
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.78
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -43.8
Return on Equity (ttm) -85.3
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -4.26
Qtrly Earnings Growth 0
Operating Cash Flow -212 (M)
Levered Free Cash Flow -119 (M)

Stock Valuations

PE Ratio -4.1
PEG Ratio -0.4
Price to Book value 5.04
Price to Sales 0
Price to Cash Flow -5.44

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.